Antibacteroides and beta-lactamase inhibitory activities of moxalactam.
D001441:Bacteroides fragilis / Q000187:drug effects / Q000201:enzymology*; D002438:Cefoperazone; D002439:Cefotaxime / Q000031:analogs & derivatives / Q000494:pharmacology; D002440:Cefoxitin / Q000494:pharmacology; D015296:Ceftizoxime; D002511:Cephalosporins / Q000494:pharmacology*; D002513:Cephamycins / Q000494:pharmacology*; D066298:In Vitro Techniques; D009070:Moxalactam; D001618:beta-Lactamases / Q000378:metabolism*
D002511:Cephalosporins; D002513:Cephamycins; D002440:Cefoxitin; D002438:Cefoperazone; D015296:Ceftizoxime; D001618:beta-Lactamases; D002439:Cefotaxime; D009070:Moxalactam